Covid-19: Campaigners accuse Pfizer of blocking access to antiviral for trials in poorer countries Post date 17 March 2022 ← Covid-19: Evusheld is approved in UK for prophylaxis in immunocompromised people → Ukraine’s children: use evidence to support child protection in emergencies